

BCM Cardiology
971 posts

@BCMHeart
The Section of Cardiology at @BCMHouston is nationally and internationally recognized for its outstanding clinical and scientific research programs.



Congratulations to Christie Ballantyne, MD, recipient of the 2026 W. Virgil Brown Distinguished Achievement Award!🏅 The highest honor conferred by the NLA, this award recognizes outstanding contributions to the diagnosis and treatment of lipid disorders. Dr. Ballantyne's decades of leadership in cardiology, cardiometabolic disease prevention, and lipid science make him a truly deserving recipient. Don't miss his Award Lectureship on June 12 at #NLASessions: "My Journey as a Researcher, Clinician, and Patient in the Field of Lipids and Atherosclerosis: Setbacks, Advances, and Opportunities." @CBallantyneMD #Lipidology #CardiometabolicHealth #PreventiveCardiology



New Focus on Fellows and Early-Career EPs article by @DrHaloot Finding value in the third year of cardiology fellowship in the new age of an accelerated pathway to electrophysiology heartrhythmcasereports.com/article/S2214-…






In @LipidJournal we discuss our experience @BCMHeart of the impact of genetic testing for FH on clinical practice: - Majority diagnoses by clinical criteria before testing ⬇️ LDL-C ⬆️ PCSK9i prescriptions @CBallantyneMD @LaylaAbushamat @vijay_nambi sciencedirect.com/science/articl…

Our latest review in @ATHjournal looks at current and upcoming advances in PCSK9 inhibition for LDL-C lowering & ASCVD prevention: mAbs → siRNA → oral agents → gene editing. #CardioTwitter #Lipidology #PCSK9 @brettsmansfield @CBallantyneMD atherosclerosis-journal.com/article/S0021-…

Now on @Medscape : @CBallantyneMD discusses why statins alone aren’t always enough. Watch the full discussion: lnkd.in/gCsPcxg3 #Cardiology #Cholesterol #LDL #PreventiveCardiology #HeartHealth #Medscape #BaylorCollegeOfMedicine #TexasHeart

Where is cardiovascular science headed next? @CBallantyneMD joined fellow AHA 2025 Distinguished Scientist honorees on Aha! with @JAHA_AHA to discuss discovery, career journeys, and what’s ahead for the field. 🎥 Watch: youtube.com/watch?v=-HcSSy…



Oral PCSK9 Therapy And The Future Of Heart Disease - Dr. Christie M. Ballantyne, MD - @CBallantyneMD @bcmhouston & Dr. Alexander Tal, MD @ProgressPotent1 @irat1onal @Merck @RealChemistry_ #Cardiology #Atherosclerosis #HeartDiseasePrevention #Enlicitide #PCSK9 - youtube.com/watch?v=ANPedC…











We are accepting applications for our preventive cardiology fellowship at Baylor College of Medicine. Pl submit applications to vnambi@bcm.edu by dec 6 if interested @CBallantyneMD @LaylaAbushamat @ASPCardio @nationallipid

🎙️NEW #AHA25 #LBCT Interview 🌟 Dr @CBallantyneMD discusses findings from the CORALreef #HeFH trial, investigating safety and efficacy of oral #PCSK9 inhibitor, enlicitide decanoate, in familial #hypercholesterolemia and high-risk patients. 📽️Watch here👉 ow.ly/qF5X50Xp5yb 📊Findings included around 50% reductions in apolipoprotein B, reductions in LDL cholesterol, and a good safety profile. #AHA2025 #CardioEd